通过基于生理学的动力模型预测饮食中蜂植物雌激素的体内度
Maja Stevanoska1, Karsten Beekmann2, Ans Punt2
1Department of Health Sciences and Technology, ETH Zurich, Switzerland.
概括
像8-prenylnaringenin (8-PN) 和异桑醇 (iXN) 这样的多,用于治疗更年期症状. 一个新的模型预测了它们在组织中的低纳米分子度,有助于评估潜在内分泌干扰的风险.
科学领域:
- 内分泌学 在内分泌学.
- 药理动力学 药理动力学
- 毒理学 毒理学 毒理学
背景情况:
- 含有前化多的取物,如8-prenylnaringenin (8-PN) 和异桑醇 (iXN),是治疗绝经后症状的热门天然替代品.
- 这些化合物由于与内源性雌激素的结构相似性,表现出雌激素受体激素激素活性.
- 8-PN 具有强大的植物雌激素活性,引发了人们对潜在的内分泌干扰和人类健康风险的担忧.
研究的目的:
- 为了解决缺乏蜂多的毒动力学数据,特别是目标组织中的体内度.
- 开发和使用一个根据女性生理学量身定制的基于生理学动力学 (PBK) 模型来预测内部暴露水平.
- 评估与饮食补充蜂多醇相关的潜在健康风险.
主要方法:
- 开发一种特定于女性生理学的生理基础动力学 (PBK) 模型.
- 模拟现实的饮食暴露场景,以预测蜂多醇度.
- 在血液和标组织中预测的异antohumol (iXN) 和8-prenylnaringenin (8-PN) in vivo度的量化.
主要成果:
- 该PBK模型成功预测了在食补充剂下蜂多的内部度.
- 目标组织中iXN和8-PN的预测度达到了低纳米分子范围.
- 该研究提供了关于这些植物雌激素的内部暴露水平的关键数据.
结论:
- 这项研究有助于更好地了解饮食后的iXN和8-PN的内部度.
- 这些发现直接适用于用于更年期症状管理的蜂多的风险评估.
- 需要进一步研究蜂多的毒动力学和潜在的内分泌干扰作用.
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
38
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
38
Physiological Pharmacokinetic Models: Assumption with Protein Binding
30
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
30
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
26
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
26
Pharmacokinetic Models: Overview
577
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
577
Model Approaches for Pharmacokinetic Data: Physiological Models
28
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
28
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
56
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
56


